benefits of glp 1 beyond weight loss GLP-1 for and Diabetes Long-term Success of GLP-1s Hinges
Description
Patients with kidney disease may require modified protein goals under medical supervision

What is the risk of muscle loss during GLP-1 research

The observational nature of our data precluded inference of causality, which might be confirmed in future research, such as in ongoing randomized controlled trials evaluating the efficacy of tirzepatide in improving CV and kidney outcomes compared with GLP-1 agonists and in treating patients with heart failure with preserved ejection fraction.
Why Tackling Weight Matters Carrying extra weight increases the risk of developing serious health issues like type 2 diabetes, heart disease, and high blood pressure

With GLP-1s still relatively new on the scene for their weight loss indication, were only just beginning to see published data on medication persistence rates, and very little in the peer-reviewed literature

They have been used for years to help manage type 2 diabetes
